# Liquid biopsy

> A figure of what a blood sample reveals about a tumour. Three 3D scenes show the analytes of a liquid biopsy — circulating tumour cells (single and in platelet-cloaked clusters), circulating tumour DNA as nucleosome-sized fragments, and exosomes — and how CTCs are captured on an anti-EpCAM microchip. The three analytes and their real sizes are set out alongside.

- Page: https://www.labcanvas.com/templates/cancer-biology/liquid-biopsy
- Open in the LabCanvas editor (LabCanvas account): https://www.labcanvas.com/editor.html?template=liquid-biopsy
- Updated: 2026-10-14
- Category: Cancer biology
- Method: Graphical abstract
- Product: Tumour analytes read from a blood draw: CTCs, ctDNA and exosomes
- Key result: cfDNA peaks at ~166 bp (Lo 2010); tumour ctDNA enriched at ~90–150 bp (Mouliere 2018); exosomes ~100 nm (Kalluri & LeBleu 2020); the CTC-chip runs whole blood over ~78,000 anti-EpCAM microposts (Nagrath 2007)
- Figure: 1920 × 1080 px, 43 editable layers

## Steps

1. **What blood carries**: Circulating tumour cells (single and in platelet-cloaked clusters), cell-free and tumour DNA, and exosomes travel in the plasma among the blood cells (Wan et al. 2017)
2. **ctDNA**: Cell-free DNA is cut like nucleosomes and peaks at ~166 bp; tumour-derived ctDNA is shorter, enriched at ~90–150 bp (Lo et al. 2010; Mouliere et al. 2018)
3. **Exosomes**: Endosome-derived vesicles about 100 nm across carry tumour nucleic acids and proteins (Kalluri & LeBleu 2020)
4. **Capturing CTCs**: CTCs are caught from whole blood on anti-EpCAM-coated microposts while blood cells flow past (Nagrath et al. 2007)

## Uses

- Diagnostics review and graphical-abstract figures
- Talks on circulating biomarkers
- Teaching the analytes of a liquid biopsy

## References

1. Nagrath et al., “Isolation of rare circulating tumour cells in cancer patients by microchip technology”, Nature 2007. https://doi.org/10.1038/nature06385 (primary)
2. Lo et al., “Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus”, Sci. Transl. Med. 2010. https://doi.org/10.1126/scitranslmed.3001720 (primary)
3. Mouliere et al., “Enhanced detection of circulating tumor DNA by fragment size analysis”, Sci. Transl. Med. 2018. https://doi.org/10.1126/scitranslmed.aat4921 (primary)
4. Kalluri & LeBleu, “The biology, function, and biomedical applications of exosomes”, Science 2020. https://doi.org/10.1126/science.aau6977 (review)
5. Wan et al., “Liquid biopsies come of age: towards implementation of circulating tumour DNA”, Nat. Rev. Cancer 2017. https://doi.org/10.1038/nrc.2017.7 (review)

Credit: Drawn in LabCanvas after Nagrath et al., Nature 2007 (doi:10.1038/nature06385); Lo et al., Sci. Transl. Med. 2010 (doi:10.1126/scitranslmed.3001720); Mouliere et al., Sci. Transl. Med. 2018 (doi:10.1126/scitranslmed.aat4921); Kalluri & LeBleu, Science 2020 (doi:10.1126/science.aau6977); and Wan et al., Nat. Rev. Cancer 2017 (doi:10.1038/nrc.2017.7). DNA and exosomes drawn enlarged; schematic.

## Questions

**What does the “Liquid biopsy” template show?** A figure of what a blood sample reveals about a tumour. Three 3D scenes show the analytes of a liquid biopsy — circulating tumour cells (single and in platelet-cloaked clusters), circulating tumour DNA as nucleosome-sized fragments, and exosomes — and how CTCs are captured on an anti-EpCAM microchip. The three analytes and their real sizes are set out alongside.

**What are the steps shown in “Liquid biopsy”?** 1. What blood carries: Circulating tumour cells (single and in platelet-cloaked clusters), cell-free and tumour DNA, and exosomes travel in the plasma among the blood cells (Wan et al. 2017). 2. ctDNA: Cell-free DNA is cut like nucleosomes and peaks at ~166 bp; tumour-derived ctDNA is shorter, enriched at ~90–150 bp (Lo et al. 2010; Mouliere et al. 2018). 3. Exosomes: Endosome-derived vesicles about 100 nm across carry tumour nucleic acids and proteins (Kalluri & LeBleu 2020). 4. Capturing CTCs: CTCs are caught from whole blood on anti-EpCAM-coated microposts while blood cells flow past (Nagrath et al. 2007).

**Which papers is “Liquid biopsy” based on?** Nagrath et al., “Isolation of rare circulating tumour cells in cancer patients by microchip technology”, Nature 2007 (doi:10.1038/nature06385); Lo et al., “Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus”, Sci. Transl. Med. 2010 (doi:10.1126/scitranslmed.3001720); Mouliere et al., “Enhanced detection of circulating tumor DNA by fragment size analysis”, Sci. Transl. Med. 2018 (doi:10.1126/scitranslmed.aat4921); Kalluri & LeBleu, “The biology, function, and biomedical applications of exosomes”, Science 2020 (doi:10.1126/science.aau6977); Wan et al., “Liquid biopsies come of age: towards implementation of circulating tumour DNA”, Nat. Rev. Cancer 2017 (doi:10.1038/nrc.2017.7).

**Can I edit the “Liquid biopsy” template?** Yes. Open it in the LabCanvas editor: all 43 layers are editable. Change the text, colours and layout, then export PNG, TIFF or PDF at the width and DPI the journal asks for.

**Do I need an account to use this template?** Not to view it here. To open and edit it, sign in to LabCanvas or create a free account (the free plan keeps up to 3 designs). Downloading the figure is part of LabCanvas Pro (US$19 a month or US$199 a year).
